MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 146 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $87,000 | -26.9% | 1,213 | 0.0% | 0.02% | -8.7% |
Q1 2022 | $119,000 | +15.5% | 1,213 | 0.0% | 0.02% | +27.8% |
Q4 2021 | $103,000 | 0.0% | 1,213 | -6.0% | 0.02% | 0.0% |
Q3 2021 | $103,000 | -18.3% | 1,291 | 0.0% | 0.02% | -10.0% |
Q2 2021 | $126,000 | -16.6% | 1,291 | 0.0% | 0.02% | -23.1% |
Q1 2021 | $151,000 | +4.9% | 1,291 | 0.0% | 0.03% | +4.0% |
Q4 2020 | $144,000 | -5.9% | 1,291 | 0.0% | 0.02% | -13.8% |
Q3 2020 | $153,000 | +4.8% | 1,291 | 0.0% | 0.03% | +11.5% |
Q2 2020 | $146,000 | +69.8% | 1,291 | 0.0% | 0.03% | +36.8% |
Q1 2020 | $86,000 | -27.1% | 1,291 | 0.0% | 0.02% | -13.6% |
Q4 2019 | $118,000 | +6.3% | 1,291 | 0.0% | 0.02% | 0.0% |
Q3 2019 | $111,000 | +58.6% | 1,291 | +93.8% | 0.02% | +69.2% |
Q2 2019 | $70,000 | -15.7% | 666 | 0.0% | 0.01% | -13.3% |
Q1 2019 | $83,000 | +10.7% | 666 | 0.0% | 0.02% | 0.0% |
Q4 2018 | $75,000 | -47.6% | 666 | 0.0% | 0.02% | -16.7% |
Q3 2018 | $143,000 | +5.9% | 666 | +38.5% | 0.02% | +5.9% |
Q2 2018 | $135,000 | – | 481 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 463,000 | $99,142,000 | 4.55% |
Rock Springs Capital Management LP | 342,000 | $73,232,000 | 2.65% |
ACUTA CAPITAL PARTNERS, LLC | 33,000 | $7,066,000 | 2.52% |
HealthCor Management, L.P. | 262,860 | $56,286,000 | 1.87% |
Baker Brothers Advisors | 1,169,278 | $250,377,000 | 1.65% |
EMORY UNIVERSITY | 11,391 | $2,439,000 | 1.60% |
PACIFIC VIEW ASSET MANAGEMENT, LLC | 8,690 | $1,862,000 | 1.48% |
GREAT POINT PARTNERS LLC | 40,400 | $8,651,000 | 1.35% |
SHIKIAR ASSET MANAGEMENT INC | 15,341 | $3,285,000 | 1.28% |
ARMISTICE CAPITAL, LLC | 80,000 | $17,130,000 | 1.03% |